Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Syndax
84
Syndax
Technology
Biotechnology
Syndax Pharmaceuticals is a late-stage clinical development oncology company focused on overcoming the problem of resistance in cancer therapy.
Suggest edits
Founded
2005
Raised
$40.5M
Follow us
Companies in the same industry
VIDA Diagnostics
Cell Medica
Personalis, Inc.
Perlstein Lab
VivoSight OCT
CDx Life
Pulmatrix
Rubicon Genomics, Inc.
Onramp BioInformatics
Genohm
Alexa global traffic share
Twitter followers
Overview
Funding
3
Add info
Latest funding
Show all
$4,947,480
Debt financing - 2014
$26,600,000
Venture capital (Series B) - 2013
Domain Associates
MPM Capital
RusnanoMedInvest
+1
Team Size
50+
Employees
I work here
Xconomy
East Coast Biotech Roundup: Ribon, Syndax, Aldeyra & More
Health
Stock markets